Let’s talk about the popular Express Scripts Holding Company (NASDAQ:ESRX). The company’s shares saw a decent share price growth in the teens level on the NasdaqGS over the last few months. As a large ...

The recent offer from Cigna provides an excellent opportunity to buy Express Scripts with limited downside. Express Script's CEO is very long Express while Cigna's CEO is short Cigna. Express is ...

So, you have a job interview at a company you really like. It’s your dream job. Your interviews are scheduled, and you ready to start to preparing. But how? Most candidates research the company, the ...

Express Scripts reported solid revenue and earnings in Q3. And the PBM thinks its future is bright. Express Scripts reported third-quarter revenue of $25.4 billion, up slightly from the $25.2 billion ...

Shares of the top pharmacy benefits manager (PBM) Express Scripts Holding Company (NASDAQ: ESRX) rose by 15.8% in December, according to data from S&P Global Market Intelligence. The catalyst?

MannKind hire David Kendall as Chief Medical Officer. Afrezza scripts come in flat. Cash estimate at about $37 million. From an investment standpoint, the addition of Kendall is not something that ...

Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found. By Chris Hamby New legislation would force ...

We all love the natural salesperson. They seem to be able to book meetings effortlessly. But of course, getting appointments is not the same as closing. To reliably close, salespeople must identify ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more. By Reed Abelson and ...